Source: BioPortfolio

Biosceptre: Biosceptre Aust Pty Ltd Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250

SummaryBiosceptre Aust Pty Ltd Biosceptre formerly known as Biosceptre International Limited is a biotechnology company that develops and commercializes antibody technologies for applications in the diagnosis and treatment of cancer. The company develops i...

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
1-25
Gavin Currie's photo - CEO of Biosceptre

CEO

Gavin Currie

CEO Approval Rating

64/100

Read more